Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorder Clinical Trial

Official title:
Experience of Using Lipano in Children With LCHAD (Long Chain Fatty Acid Oxidation Disorder)

Status Completed

Clinical Trial Summary

This is a market research, observational study to evaluate the tolerability and acceptability of an MCT based formula for infants and young people with long chain fatty acid oxidation disorder from birth to 18 months. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04400422
Study type	Interventional
Source	Dr. Schär AG / SPA
Contact
Status	Completed
Phase	N/A
Start date	June 20, 2018
Completion date	September 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04309214` - Market Research - Acceptability Study for New MCT Fat Products	N/A
Completed	`NCT04309149` - Market Research - Acceptability Study for a Range of MCT Products	N/A
Completed	`NCT04009642` - Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
Recruiting	`NCT04602325` - Systemic Biomarkers of Brain Injury From Hyperammonemia
Completed	`NCT04482049` - A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders